Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) agreed to acquire 70% of stake in Zhejiang Jingning Oujiang Capsule Co., Ltd. from Wang Shiguo and Wang Linsu for CNY 36.8 million on August 26, 2021. As of September 2, 2021, Zhejiang Wecome paid the first transaction price of CNY 11.025 million. Wang Shiguo has 78.07% and Wang Linsu has 21.93% stake in Zhejiang Jingning of which Wang Shiguo will sell 54.0741% and Wang Linsu will sell 15.9259% stake. As of September 15, 2021, Zhejiang Wecome paid the second transaction price of CNY 14.7 million. The source of funds for this transaction is Zhejiang Wecome's own funds. Zhejiang Jingning has total assets of CNY 22 million and net assets of CNY 19 million in 2021. Zhejiang Jingning has total assets of CNY 20 million, Net assets of CNY 17.7 million, Operating income of CNY 16 million and Net profit of CNY 3 million in 2020. The transaction has been reviewed and approved at the second meeting of the third board of directors held on August 26, 2021. Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) completed the acquisition of 70% of stake in Zhejiang Jingning Oujiang Capsule Co., Ltd. from Wang Shiguo and Wang Linsu on September 15, 2021.